These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7582186)

  • 1. Chemotherapy of human small-cell gastrointestinal carcinoma xenografts in nude mice.
    Aizawa K; Tanaka N; Yabusaki H; Suzuki S; Muto I; Nishimaki T; Suzuki T; Hatakeyama K; Tanaka O
    Surg Oncol; 1995 Jun; 4(3):139-45. PubMed ID: 7582186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etoposide-cisplatin and thoracic radiation therapy salvage of incomplete responders to a noncisplatin induction regimen for limited and extensive small-cell carcinoma of the lung.
    Shaw EG; Frytak S; Eagan RT; Richardson RL; Creagan ET; Jett JR; Foote RL; Su JQ; Schaid DJ; Lee RE
    Am J Clin Oncol; 1996 Apr; 19(2):154-8. PubMed ID: 8610640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
    Glisson B; Lee JS; Palmer J; Fossella F; Shin DM; Murphy WK; Perez-Soler R; Hong WK
    Cancer; 1998 Jan; 82(2):301-8. PubMed ID: 9445186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
    Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
    J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding a reverser (verapamil) to combined chemotherapy overrides resistance in small cell lung cancer xenografts.
    Arvelo F; Poupon MF; Bichat F; Grossin F; Bourgeois Y; Jacrot M; Bastian G; Le Chevalier T
    Eur J Cancer; 1995 Oct; 31A(11):1862-8. PubMed ID: 8541114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraneoplastic subacute cutaneous lupus erythematosus: report of a case associated with cancer of the lung.
    Brenner S; Golan H; Gat A; Bialy-Golan A
    Dermatology; 1997; 194(2):172-4. PubMed ID: 9094469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
    Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
    Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term results of surgery and chemotherapy in small cell lung cancer.
    Rea F; Callegaro D; Favaretto A; Loy M; Paccagnella A; Fantoni U; Festi G; Sartori F
    Eur J Cardiothorac Surg; 1998 Oct; 14(4):398-402. PubMed ID: 9845145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Randomised phase II study evaluating oral combination chemotherapy (CCNU, cyclophosphamide, etoposide) and intravenous chemotherapy as second-line treatment for relapsed small cell bronchial carcinoma (Trial GFPC0501)].
    Gervais R; Le Guen Y; Le Caer H; Paillotin D; Chouaid C;
    Rev Mal Respir; 2007 May; 24(5):653-8. PubMed ID: 17519820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination chemotherapy of HO-221, a derivative of benzoylphenylurea with various anticancer agents against human cancer xenografts in nude mice].
    Fujita F; Fujita M; Inaba H; Sugimoto T; Okuyama Y; Taguchi T
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2263-70. PubMed ID: 1929447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
    Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
    Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current data concerning neoadjuvant chemotherapy].
    Depierre A
    Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S11-3. PubMed ID: 16719148
    [No Abstract]   [Full Text] [Related]  

  • 13. Infusion cisplatin chemotherapy and hyperfractionated thoracic radiotherapy for small-cell lung cancer.
    Frytak S; Shaw EG; Jett JR; Richardson RL; Foote RL; Creagan ET; Eagan RT; Su JQ
    Am J Clin Oncol; 1996 Apr; 19(2):193-8. PubMed ID: 8610649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Chemotherapy for unresectable pancreatoblastoma".
    Hord JD; Janco RL
    Med Pediatr Oncol; 1996 Jun; 26(6):432-3. PubMed ID: 8614383
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587).
    Chang AY; Kim K; Boucher H; Bonomi P; Stewart JA; Karp DD; Blum RH
    Cancer; 1998 Jan; 82(2):292-300. PubMed ID: 9445185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant oral etoposide plus cisplatin (EoP) following sequential doxorubicin/cyclophosphamide (AC) and docetaxel (T) in early breast cancer patients with 4 or more positive lymph nodes (10 years follow-up).
    Icli F; Akbulut H; Onur H; Yalcin B; Demirkazık A; Senler FÇ
    Breast; 2011 Apr; 20(2):155-7. PubMed ID: 20951586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of a multidrug-resistant human small-cell lung cancer xenograft to chemotherapy.
    Arvelo F; Poupon MF; Goguel AF; Lizard G; Bourgeois Y; Arriagada R; Le Chevalier T
    J Cancer Res Clin Oncol; 1993; 120(1-2):17-23. PubMed ID: 7903668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small cell carcinoma of gastro-oesophageal junction with remarkable response to chemo-radiotherapy.
    Matsunaga M; Miwa K; Noguchi T; Sasaki Y
    BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22843758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug-resistant gene expression in small-cell lung cancer.
    Savaraj N; Wu CJ; Xu R; Lampidis T; Lai S; Donnelly E; Solomon J; Feun LG
    Am J Clin Oncol; 1997 Aug; 20(4):398-403. PubMed ID: 9256898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Objective response to epirubicin and lonidamine. A case of advanced thymoma previously treated with the ADOC scheme and unresponsive to paclitaxel plus cyclophosphamide.
    Berruti A; Tampellini M; Gorzegno G; Dogliotti L
    Chest; 1997 May; 111(5):1473-4. PubMed ID: 9149629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.